Literature DB >> 32193209

Patient-reported impact of symptoms in Huntington disease: PRISM-HD.

Alistair M Glidden1, Elizabeth A Luebbe1, Molly J Elson1, Steven B Goldenthal1, Christopher W Snyder1, Christine E Zizzi1, E Ray Dorsey1, Chad R Heatwole2.   

Abstract

OBJECTIVE: To determine the frequency and relative importance of symptoms experienced by adults with Huntington disease (HD) and to identify factors associated with a higher disease burden.
METHODS: We performed 40 qualitative interviews (n = 20 with HD, n = 20 caregivers) and analyzed 2,082 quotes regarding the symptomatic burden of HD. We subsequently performed a cross-sectional study with 389 participants (n = 156 with HD [60 of whom were prodromal], n = 233 caregivers) to assess the prevalence and relative importance (scale 0-4) of 216 symptoms and 15 symptomatic themes in HD. Cross-correlation analysis was performed based on sex, disease duration, age, number of CAG repeats, disease burden, Total Functional Capacity score, employment status, disease status, and ambulatory status.
RESULTS: The symptomatic themes with the highest prevalence in HD were emotional issues (83.0%), fatigue (82.5%), and difficulty thinking (77.0%). The symptomatic themes with the highest relative importance to participants were difficulty thinking (1.91), impaired sleep or daytime sleepiness (1.90), and emotional issues (1.81). High Total Functional Capacity scores, being employed, and having prodromal HD were associated with a lower prevalence of symptomatic themes. Despite reporting no clinical features of the disease, prodromal individuals demonstrated high rates of emotional issues (71.2%) and fatigue (69.5%). There was concordance between the prevalence of symptoms reported by manifest individuals and caregivers.
CONCLUSIONS: Many symptomatic themes affect the lives of those with HD. These themes have a variable level of importance to the HD population and are identified both by those with HD and by their caregivers.
© 2020 American Academy of Neurology.

Entities:  

Year:  2020        PMID: 32193209     DOI: 10.1212/WNL.0000000000008906

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Multidimensional Apathy: The Utility of the Dimensional Apathy Scale in Huntington's Disease.

Authors:  Kelly J Atkins; Sophie C Andrews; Trevor T-J Chong; Julie C Stout
Journal:  Mov Disord Clin Pract       Date:  2021-02-12

2.  Sex Differences in Huntington's Disease: Evaluating the Enroll-HD Database.

Authors:  Samantha Hentosh; Liang Zhu; Jorge Patino; J Weldon Furr; Natalia P Rocha; Erin Furr Stimming
Journal:  Mov Disord Clin Pract       Date:  2021-03-08

3.  Perceived Effects of Neuropsychiatric Symptoms on Functional Status in Early-stage Huntington Disease.

Authors:  Jessie S Gibson; Bethany A Rhoten; Sheila H Ridner; Daniel O Claassen
Journal:  West J Nurs Res       Date:  2021-02-05       Impact factor: 1.774

4.  State-of-the-art pharmacological approaches to reduce chorea in Huntington's disease.

Authors:  Jessie S Gibson; Daniel O Claassen
Journal:  Expert Opin Pharmacother       Date:  2021-02-08       Impact factor: 4.103

5.  Clinical Outcomes and Selection Criteria for Prodromal Huntington's Disease Trials.

Authors:  Douglas R Langbehn; Steven Hersch
Journal:  Mov Disord       Date:  2020-07-20       Impact factor: 10.338

Review 6.  Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges.

Authors:  Virginija Danylaité Karrenbauer; Robert A Harris; Jinming Han; Violeta Chitu; E Richard Stanley; Zbigniew K Wszolek
Journal:  Cell Mol Life Sci       Date:  2022-04-02       Impact factor: 9.207

Review 7.  Social Withdrawal in Huntington's Disease: A Scoping Review.

Authors:  Jessie S Gibson; Kristen Springer
Journal:  J Huntingtons Dis       Date:  2022

Review 8.  Advances and Perspectives in Dental Pulp Stem Cell Based Neuroregeneration Therapies.

Authors:  Jon Luzuriaga; Yurena Polo; Oier Pastor-Alonso; Beatriz Pardo-Rodríguez; Aitor Larrañaga; Fernando Unda; Jose-Ramon Sarasua; Jose Ramon Pineda; Gaskon Ibarretxe
Journal:  Int J Mol Sci       Date:  2021-03-29       Impact factor: 5.923

Review 9.  Do Changes in Synaptic Autophagy Underlie the Cognitive Impairments in Huntington's Disease?

Authors:  Hilary Grosso Jasutkar; Ai Yamamoto
Journal:  J Huntingtons Dis       Date:  2021
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.